Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8395049 | Toxicon | 2016 | 8 Pages |
Abstract
Batroxase presents thrombolytic activity in vivo, thus demonstrating a possible therapeutic potential. The inactivation of the metalloprotease by alpha 2-macroglobulin may reduce its activity, but also its potential side effects, as seen for bleeding time.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry, Genetics and Molecular Biology (General)
Authors
Anna L. Jacob-Ferreira, Danilo L. Menaldo, Carolina P. Bernardes, Marco A. Sartim, Célio D. de Angelis, José E. Tanus-Santos, Suely V. Sampaio,